Inogen, Inc. INGN is well-poised for growth in the coming quarters, courtesy of high prospects in the portable oxygen ...

Inogen (INGN) could be a solid addition to your ... For the fiscal year ending December 2024, this produces oxygen concentrators for patients suffering from chronic respiratory conditions is ...

After more than two decades of being primarily known for exclusively selling one product, portable oxygen containers, Goleta-based Inogen has spent the last couple of years branching out. That is ...

Inogen, Inc. INGN recently announced a strategic collaboration with Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.

Inogen, Inc. is a medical technology company, which engages in the development, manufacture, and marketing of portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to ...

Needham analyst Michael Matson has maintained their neutral stance on INGN stock, giving a Hold rating on January 14.Invest with Confidence: ...

This raises our optimism about the stock. In October 2024, Inogen commenced the U.S. market release of the Rove 4 Portable Oxygen Concentrator (POC). This is likely to have witnessed a robust ...

More on INGN’s Robust Product Portfolio Inogen’s expanding product portfolio is a significant driver of its growth. It offers a range of oxygen concentrator solutions for both portable and ...